Gatifloxacin ophthalmic Alternatives Compared
| Gatifloxacin ophthalmic | Lotemax (loteprednol) | Sulfacetamide sodium ophthalmic |
|
|---|
| Gatifloxacin ophthalmic | Lotemax (loteprednol) | Sulfacetamide sodium ophthalmic |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Conjunctivitis - Bacterial, Conjunctivitis, Ophthalmic Surgery. Gatifloxacin ophthalmic may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Conjunctivitis, Keratitis, Iritis, Cyclitis, Postoperative Ocular Inflammation, Rosacea, Seasonal Allergic Conjunctivitis. Lotemax may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Conjunctivitis, Eye Conditions, Trachoma. Sulfacetamide sodium ophthalmic may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||||||||||
| More about Gatifloxacin ophthalmic | More about Lotemax (loteprednol) | More about Sulfacetamide sodium ophthalmic | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Gatifloxacin ophthalmic has an average rating of 7.6 out of 10 from a total of 8 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 13% reported a negative effect. |
Lotemax has an average rating of 6.6 out of 10 from a total of 18 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 33% reported a negative effect. |
Sulfacetamide sodium ophthalmic has an average rating of 8.3 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Gatifloxacin ophthalmic side effects |
View all Lotemax side effects |
|||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Gatifloxacin ophthalmic prices |
View all Lotemax prices |
|
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Zymar, Zymaxid | Other loteprednol brands include: Alrex, Eysuvis, Inveltys, Lotemax SM | AK-Sulf, Bleph-10, Cetamide | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
A total of 42 drugs are known to interact with Lotemax:
|
A total of 1 drugs are known to interact with Sulfacetamide sodium ophthalmic:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
April 15, 2011 |
July 21, 1946 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.